50ul primary antibodies Search Results


anti 8 ohdg primary antibody  (Novus Biologicals)
93
Novus Biologicals anti 8 ohdg primary antibody
Anti 8 Ohdg Primary Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/50ul+primary+antibodies/8-oxo-dG+Antibody/pm37598346-48-6-9
Average 93 stars, based on 1 article reviews
anti 8 ohdg primary antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
primary antibodies  (Proteintech)
96
Proteintech primary antibodies
Primary Antibodies, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/50ul+primary+antibodies/GRP78%2FBIP+Antibody/pm39905002-279-1-31
Average 96 stars, based on 1 article reviews
primary antibodies - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
antibodies anti ha  (Abbkine Inc)
86
Abbkine Inc antibodies anti ha
Antibodies Anti Ha, supplied by Abbkine Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/50ul+primary+antibodies/anti+ha/pmc12501976-338-5-9
Average 86 stars, based on 1 article reviews
antibodies anti ha - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
anti e cadherin  (Proteintech)
96
Proteintech anti e cadherin
Anti E Cadherin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/50ul+primary+antibodies/E-cadherin+Polyclonal+antibody/pmc12375134-43-13-14
Average 96 stars, based on 1 article reviews
anti e cadherin - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
anti pten  (Proteintech)
96
Proteintech anti pten
Role of PREX2 in ccRCC with SD was confirmed by in vivo and in vitro assays. (A) The PREX2 OE 786‐O and OS‐RC‐2 cells were successfully transfected, as demonstrated by RT‐qPCR. Negative control (NC). (B–C) Wound‐healing assay reflected the migration of PREX2 OE 786‐O and OS‐RC‐2 cells and negative control (NC). *represented p < 0.05. Scale bars, 200 μm. (D, E) Transwell assay reflected the migration and invasion of PREX2 OE 786‐O and OS‐RC‐2 cells. *represented p < 0.05. Scale bars, 200 μm. (F) Western blot analysis showed the protein <t>(PTEN)</t> in Caki‐1 cells and the protein <t>(PTEN,</t> <t>AKT,</t> and pAKT) levels of OS‐RC‐2 cells after overexpressing PREX2. (G, H) Injecting PREX2 OE OS‐RC‐2 cells into nude mice to form subcutaneous tumors. (I) RT‐qPCR showed the RNA ( PTEN , AKT , and p AKT ) levels of subcutaneous tumors from nude mice. *represented p < 0.05. (J) Schematic representation of the molecular mechanism underlying the transformation of ccRCC into ccRCC with SD.
Anti Pten, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/50ul+primary+antibodies/PTEN+Antibody/pmc12666471-111-4-9
Average 96 stars, based on 1 article reviews
anti pten - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
wells  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology wells
Role of PREX2 in ccRCC with SD was confirmed by in vivo and in vitro assays. (A) The PREX2 OE 786‐O and OS‐RC‐2 cells were successfully transfected, as demonstrated by RT‐qPCR. Negative control (NC). (B–C) Wound‐healing assay reflected the migration of PREX2 OE 786‐O and OS‐RC‐2 cells and negative control (NC). *represented p < 0.05. Scale bars, 200 μm. (D, E) Transwell assay reflected the migration and invasion of PREX2 OE 786‐O and OS‐RC‐2 cells. *represented p < 0.05. Scale bars, 200 μm. (F) Western blot analysis showed the protein <t>(PTEN)</t> in Caki‐1 cells and the protein <t>(PTEN,</t> <t>AKT,</t> and pAKT) levels of OS‐RC‐2 cells after overexpressing PREX2. (G, H) Injecting PREX2 OE OS‐RC‐2 cells into nude mice to form subcutaneous tumors. (I) RT‐qPCR showed the RNA ( PTEN , AKT , and p AKT ) levels of subcutaneous tumors from nude mice. *represented p < 0.05. (J) Schematic representation of the molecular mechanism underlying the transformation of ccRCC into ccRCC with SD.
Wells, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/50ul+primary+antibodies/Tau+Antibody/bio_rxiv__2025__09__05__672953-248-9-16
Average 96 stars, based on 1 article reviews
wells - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Role of PREX2 in ccRCC with SD was confirmed by in vivo and in vitro assays. (A) The PREX2 OE 786‐O and OS‐RC‐2 cells were successfully transfected, as demonstrated by RT‐qPCR. Negative control (NC). (B–C) Wound‐healing assay reflected the migration of PREX2 OE 786‐O and OS‐RC‐2 cells and negative control (NC). *represented p < 0.05. Scale bars, 200 μm. (D, E) Transwell assay reflected the migration and invasion of PREX2 OE 786‐O and OS‐RC‐2 cells. *represented p < 0.05. Scale bars, 200 μm. (F) Western blot analysis showed the protein (PTEN) in Caki‐1 cells and the protein (PTEN, AKT, and pAKT) levels of OS‐RC‐2 cells after overexpressing PREX2. (G, H) Injecting PREX2 OE OS‐RC‐2 cells into nude mice to form subcutaneous tumors. (I) RT‐qPCR showed the RNA ( PTEN , AKT , and p AKT ) levels of subcutaneous tumors from nude mice. *represented p < 0.05. (J) Schematic representation of the molecular mechanism underlying the transformation of ccRCC into ccRCC with SD.

Journal: Cancer Science

Article Title: Integration of scRNA ‐Seq and scATAC ‐Seq Reveals Malignant Characteristics of Sarcomatoid Clear Cell Renal Cell Carcinoma

doi: 10.1111/cas.70220

Figure Lengend Snippet: Role of PREX2 in ccRCC with SD was confirmed by in vivo and in vitro assays. (A) The PREX2 OE 786‐O and OS‐RC‐2 cells were successfully transfected, as demonstrated by RT‐qPCR. Negative control (NC). (B–C) Wound‐healing assay reflected the migration of PREX2 OE 786‐O and OS‐RC‐2 cells and negative control (NC). *represented p < 0.05. Scale bars, 200 μm. (D, E) Transwell assay reflected the migration and invasion of PREX2 OE 786‐O and OS‐RC‐2 cells. *represented p < 0.05. Scale bars, 200 μm. (F) Western blot analysis showed the protein (PTEN) in Caki‐1 cells and the protein (PTEN, AKT, and pAKT) levels of OS‐RC‐2 cells after overexpressing PREX2. (G, H) Injecting PREX2 OE OS‐RC‐2 cells into nude mice to form subcutaneous tumors. (I) RT‐qPCR showed the RNA ( PTEN , AKT , and p AKT ) levels of subcutaneous tumors from nude mice. *represented p < 0.05. (J) Schematic representation of the molecular mechanism underlying the transformation of ccRCC into ccRCC with SD.

Article Snippet: The primary antibodies were anti‐ PTEN (mouse antihuman, 1:6000, Proteintech, 60,300–1‐IG‐50UL), anti‐ AKT (rabbit antihuman, 1:7000, Proteintech, 10,176–2‐AP‐50UL), antiphospho‐Akt (rabbit antihuman, 1:1000, Bioss, bs‐2720R), and anti‐E‐cadherin (rabbit antihuman, 1:5000, Thermo Fisher Scientific, 701,134).

Techniques: In Vivo, In Vitro, Transfection, Quantitative RT-PCR, Negative Control, Wound Healing Assay, Migration, Transwell Assay, Western Blot, Transformation Assay